Company
MyHealthChecked plc
Headquarters: Cardiff, United Kingdom
Employees: 10
CEO: Ms. Penelope Jane McCormick
Market Cap
£8.9 Million
GBP as of Jan. 1, 2025
US$11.1 Million
MyHealthChecked plc Categories
United Kingdom Healthcare Medical DevicesUnited Kingdom Healthcare United Kingdom Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
MyHealthChecked Plc, a home-testing healthcare company, develops and commercializes at-home healthcare and wellness test kits in the United Kingdom. The company provides MyLotus/MYLO products for trusted ovulation, conception, and fertility advice and tracking, as well as up to date information regarding fertility for customers. It also offers a range of at-home DNA and RNA tests; and COVID-19 PCR nasal swab test kit for at-home use. The company was formerly known as Concepta PLC and changed its name to MyHealthChecked Plc in December 2020. MyHealthChecked Plc was incorporated in 2008 and is headquartered in Cardiff, the United Kingdom.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | June 30, 2023 |
| Revenue TTM | £14.9 M |
| EBITDA | £1.0 M |
| Gross Profit TTM | £4.6 M |
| Profit Margin | 1.27% |
| Operating Margin | -16.40% |
| Quarterly Revenue Growth | -74.90% |
Stocks & Indices
MyHealthChecked plc has the following listings and related stock indices.
Stock: LSE: MHC wb_incandescent